Skip Navigation



Annals of Oncology Advance Access published online on October 29, 2009
Annals of Oncology, doi:10.1093/annonc/mdp480
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Edeline, J.
Right arrow Articles by Patard, J.-J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edeline, J.
Right arrow Articles by Patard, J.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma

The first 10% of the full text of this article appears below.

The development of antiangiogenic agents targeting the vascular endothelial growth factor (VEGF) pathway (sunitinib, sorafenib, bevacizumab and temsirolimus) has revolutionized the treatment of metastatic renal clear-cell carcinoma. Adverse events attributed to these agents targeting the vascularization include cardiovascular effects. We report here a case of aortic dissection in a patient treated by sunitinib and discuss the . . . [Full Text of this Article]

disclosure

J. Edeline1,*, B. Laguerre1, Y. Rolland2 and J.-J. Patard3

1 Department of Medical Oncology, Eugene Marquis Comprehensive Cancer Center
2 Department of Radiology, Eugene Marquis Comprehensive Cancer Center
3 Department of Urology, Pontchaillou University Hospital, Rennes, France

* (E-mail: julien.edeline@free.fr)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?